PMID- 32154025
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220413
IS  - 2057-3804 (Electronic)
IS  - 2057-3804 (Linking)
VI  - 5
DP  - 2019
TI  - Validation of the Spanish version of the MD Anderson symptom inventory - heart 
      failure (MDASI-HF-Spanish) module.
PG  - 19
LID - 10.1186/s40959-019-0055-4 [doi]
LID - 19
AB  - BACKGROUND: The lack of a validated symptom assessment instrument in Spanish for 
      patients with cancer and heart failure (HF) can affect the care and impede the 
      recruitment and participation of Spanish-speaking patients in clinical trials. 
      Spanish is the second most common language spoken by the largest and most rapidly 
      growing racial/ethnic minority group in the United States. To bridge the language 
      barrier and improve symptom management in Spanish-speaking patients with cancer 
      and HF, the MD Anderson Symptom Inventory-Heart Failure (MDASI-HF) was translated 
      to Spanish (MDASI-HF- Spanish). AIM: To validate the MDASI-HF-Spanish symptom 
      assessment instrument. METHODS: Following standard forward and backward 
      translation of the original and previously validated English version of the 
      MDASI-HF, a cognitive debriefing with nine native Spanish speaking participants 
      was conducted to evaluate the participants' understanding and comprehension of 
      the MDASI-HF-Spanish. To examine the comprehensibility, acceptability and 
      psychometric properties of the translated instrument, the MDASI-HF-Spanish was 
      tested in a convenience sample of 50 Spanish speaking patients with a diagnosis 
      of cancer and HF. Evidence for the psychometric validity of the MDASI-HF-Spanish 
      was demonstrated via its internal consistency reliability and known-group 
      validity. RESULTS: Overall, the participants had no problems with the 
      understandability, readability, or number of questions asked. The 
      MDASI-HF-Spanish subscales showed good internal consistency reliability, with a 
      Cronbach's coefficient alpha of 0.94 (13 core cancer symptoms), 0.92 (8 heart 
      failure symptoms), and 0.90 (6 interference items) respectively. The 
      MDASI-HF-Spanish was able to differentiate the functional status between patients 
      based on the New York Heart Association (NYHA) functional classification. 
      CONCLUSIONS: The MDASI-HF-Spanish is linguistically and psychometrically valid 
      with ease of completion, relevance, and comprehensibility among the participants, 
      and it can be a useful tool for clinical management and research purposes.
CI  - (c) The Author(s). 2019.
FAU - Fadol, Anecita
AU  - Fadol A
AUID- ORCID: 0000-0001-8779-4787
AD  - 1Department of Nursing, The University of Texas MD Anderson Cancer Center, 1400 
      Holcombe Boulevard, Unit 0456, Houston, TX 77030-4009 USA. ISNI: 0000 0001 2291 
      4776. GRID: grid.240145.6
FAU - Buitrago, Joaquin
AU  - Buitrago J
AD  - 2Nursing Education, The University of Texas MD Anderson Cancer Center, 1400 
      Holcombe Boulevard, Unit 0456, Houston, TX 77030-4009 USA. ISNI: 0000 0001 2291 
      4776. GRID: grid.240145.6
FAU - Diaz, Maria C
AU  - Diaz MC
AD  - 2Nursing Education, The University of Texas MD Anderson Cancer Center, 1400 
      Holcombe Boulevard, Unit 0456, Houston, TX 77030-4009 USA. ISNI: 0000 0001 2291 
      4776. GRID: grid.240145.6
FAU - Shelton, Valerie
AU  - Shelton V
AD  - 1Department of Nursing, The University of Texas MD Anderson Cancer Center, 1400 
      Holcombe Boulevard, Unit 0456, Houston, TX 77030-4009 USA. ISNI: 0000 0001 2291 
      4776. GRID: grid.240145.6
FAU - Harty, Carolyn
AU  - Harty C
AD  - 1Department of Nursing, The University of Texas MD Anderson Cancer Center, 1400 
      Holcombe Boulevard, Unit 0456, Houston, TX 77030-4009 USA. ISNI: 0000 0001 2291 
      4776. GRID: grid.240145.6
FAU - Mendoza, Tito R
AU  - Mendoza TR
AD  - 3Department of Symptom Research, The University of Texas MD Anderson Cancer 
      Center, 1400 Holcombe Boulevard, Unit 0456, Houston, TX 77030-4009 USA. ISNI: 
      0000 0001 2291 4776. GRID: grid.240145.6
LA  - eng
GR  - P30 CA016672/CA/NCI NIH HHS/United States
PT  - Journal Article
DEP - 20191204
PL  - England
TA  - Cardiooncology
JT  - Cardio-oncology (London, England)
JID - 101689938
PMC - PMC7048060
OTO - NOTNLM
OT  - Cancer
OT  - Heart failure
OT  - Linguistic validation
OT  - Spanish version
OT  - Symptom instrument 
COIS- Competing interestsThe authors declare that they have no competing interests..
EDAT- 2020/03/11 06:00
MHDA- 2020/03/11 06:01
PMCR- 2019/12/04
CRDT- 2020/03/11 06:00
PHST- 2019/08/20 00:00 [received]
PHST- 2019/10/21 00:00 [accepted]
PHST- 2020/03/11 06:00 [entrez]
PHST- 2020/03/11 06:00 [pubmed]
PHST- 2020/03/11 06:01 [medline]
PHST- 2019/12/04 00:00 [pmc-release]
AID - 55 [pii]
AID - 10.1186/s40959-019-0055-4 [doi]
PST - epublish
SO  - Cardiooncology. 2019 Dec 4;5:19. doi: 10.1186/s40959-019-0055-4. eCollection 
      2019.